Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://www.sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation COVID-19 Pregnancy Study Implementation Methods, Data, & Tools
COVID-19 Pregnancy Study Implementation
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Modular Programs
Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Modular Programs
https://www.sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools
Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-first Duration of Follow Up for New Molecular Entities Approved in 2017: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2017: First Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drugs-approved-risk-evaluation-and-mitigation Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) Assessments
Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU)
Assessments
https://www.sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-women Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations
Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools
Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-0 Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network Publications and Presentations
Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network
Publications and Presentations
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2021-13th-annual-sentinel-initiative-public-workshop 2021 13th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events
2021 13th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-second Duration of Follow Up for New Molecular Entities Approved in 2017: Second Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2017: Second Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019-first Duration of Follow Up for New Molecular Entities Approved in 2019: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2019: First Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter Quarterly Newsletter Spotlight
Quarterly Newsletter
Spotlight
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/epidiolex-prescription-cannabidiol-utilization-patterns Epidiolex (Prescription Cannabidiol) Utilization Patterns: A Descriptive Analysis Analyses
Epidiolex (Prescription Cannabidiol) Utilization Patterns: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2018-first Duration of Follow Up for New Molecular Entities Approved in 2018: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2018: First Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-confounding-variables-over-time Incidence and Prevalence of Confounding Variables Over Time in the Sentinel Distributed Database (SDD): A Descriptive Analysis Analyses
Incidence and Prevalence of Confounding Variables Over Time in the Sentinel Distributed Database (SDD): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-public-training-day-inverse-probability 2022 Sentinel Public Training Day: Inverse Probability of Treatment Weighting & Innovation Day  Sentinel Initiative Events
2022 Sentinel Public Training Day: Inverse Probability of Treatment Weighting & Innovation Day 
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/women-heart-failure Women with Heart Failure & Pregnancy Studies
Women with Heart Failure & Pregnancy
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/data-driven-approaches-improve-phenotype-sensitivity-using Data-Driven Approaches to Improve Phenotype Sensitivity Using EHR Data Publications and Presentations
Data-Driven Approaches to Improve Phenotype Sensitivity Using EHR Data
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-mother Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations
Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-pediatric-members-sentinel-distributed Characterizing Pediatric Members in the Sentinel Distributed Database Publications and Presentations
Characterizing Pediatric Members in the Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-14th-annual-sentinel-initiative-public-workshop 2022 14th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events
2022 14th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
https://www.sentinelinitiative.org/news-events/publications-presentations/scalable-phenotyping-safety-outcomes-using-electronic-health Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data Publications and Presentations
Scalable Phenotyping for Safety Outcomes Using Electronic Health Record Data
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/development-and-evaluation-electronic-health-record-ehr-information Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2) Methods, Data, & Tools
Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2)
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/understanding-use-negative-controls-assess-validity-non Understanding the Use of Negative Controls to Assess the Validity of Non-Interventional Studies of Treatment Using Real-World Evidence Sentinel Initiative Events
Understanding the Use of Negative Controls to Assess the Validity of Non-Interventional Studies of Treatment Using Real-World Evidence
Sentinel Initiative Events
https://www.sentinelinitiative.org/news-events/publications-presentations/identifying-pediatric-hypertension-real-world-data-comparing Identifying Pediatric Hypertension in Real World Data: Comparing Two Computable Phenotypes Publications and Presentations
Identifying Pediatric Hypertension in Real World Data: Comparing Two Computable Phenotypes
Publications and Presentations
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-public-training-signal-identification-among 2023 Sentinel Public Training: Signal Identification Among Infants Following Maternal Medication Use During Pregnancy & Innovation Day Sentinel Initiative Events
2023 Sentinel Public Training: Signal Identification Among Infants Following Maternal Medication Use During Pregnancy & Innovation Day
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-heart Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis Analyses
Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-0 Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Matched Analysis Analyses
Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/utilization-single-and-multiple-inhaler-triple-therapy-among-patients Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database Methods, Data, & Tools
Utilization of Single and Multiple Inhaler Triple Therapy Among Patients with COPD in the Sentinel Distributed Database
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-patterns-among-pregnant-and Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System Publications and Presentations
Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-beta-blockers-among-pediatric-population-united Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022 Publications and Presentations
Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022
Publications and Presentations
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-public-workshop-optimizing-use-postapproval-pregnancy 2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies Sentinel Initiative Events
2023 Public Workshop: Optimizing the Use of Postapproval Pregnancy Safety Studies
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-drugs-approved-risk-evaluation-and-mitigation-0 Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU): A Descriptive Analysis Analyses
Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/characterization-covid-19-vaccination-data-sdd-0 Characterization of COVID-19 Vaccination Data in the SDD Methods, Data, & Tools
Characterization of COVID-19 Vaccination Data in the SDD
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-15th-annual-sentinel-initiative-public-workshop 2023 15th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events
2023 15th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events
https://www.sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-electronic-health-record-ehr-and-claims Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests Methods, Data, & Tools
Empirical Application of the Sentinel Electronic Health Record (EHR) and Claims Data Partner Network to Address ARIA Insufficient Inferential Requests
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-sentinel-innovation-and-methods-seminar-series 2024 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events
2024 Sentinel Innovation and Methods Seminar Series
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-baloxavir-use-signal Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-biopsy Coding Trend Analyses: Biopsy Methods, Data, & Tools
Coding Trend Analyses: Biopsy
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-crohns-disease Coding Trend Analyses: Crohn's Disease Methods, Data, & Tools
Coding Trend Analyses: Crohn's Disease
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-colectomy-colostomy-and-ileostomy Coding Trend Analyses: Colectomy, Colostomy, and Ileostomy Methods, Data, & Tools
Coding Trend Analyses: Colectomy, Colostomy, and Ileostomy
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-diverticulitis-and-colitis Coding Trend Analyses: Diverticulitis and Colitis Methods, Data, & Tools
Coding Trend Analyses: Diverticulitis and Colitis
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-endoscopy Coding Trend Analyses: Endoscopy Methods, Data, & Tools
Coding Trend Analyses: Endoscopy
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/coding-trend-analyses-ulcerative-colitis Coding Trend Analyses: Ulcerative Colitis Methods, Data, & Tools
Coding Trend Analyses: Ulcerative Colitis
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-dupilumab-use-signal Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/occurrence-stroke-intracranial-hemorrhage-and-bleeding Occurrence of Stroke, Intracranial Hemorrhage, and Bleeding Outcomes Following Direct Oral Anticoagulant Use in Patients Aged 64 or Younger with Atrial Fibrillation: A Descriptive Analysis Analyses
Occurrence of Stroke, Intracranial Hemorrhage, and Bleeding Outcomes Following Direct Oral Anticoagulant Use in Patients Aged 64 or Younger with Atrial Fibrillation: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-montelukast-use-patients Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding Analyses
Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/targeted-learning-undersmoothed-lasso-propensity-score-model Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies Publications and Presentations
Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/general-framework-developing-computable-clinical-phenotype A General Framework for Developing Computable Clinical Phenotype Algorithms Publications and Presentations
A General Framework for Developing Computable Clinical Phenotype Algorithms
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/finding-uncoded-anaphylaxis-electronic-health-records Finding Uncoded Anaphylaxis in Electronic Health Records to Estimate the Sensitivity of ICD10 Codes Publications and Presentations
Finding Uncoded Anaphylaxis in Electronic Health Records to Estimate the Sensitivity of ICD10 Codes
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-pediatric-demographics-and-enrollment-0 Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: An Updated Descriptive Analysis Analyses
Characterization of Pediatric Demographics and Enrollment in the Sentinel Distributed Database: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers-0 Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization Studies
Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/description-active-risk-identification-and-analysis-system A Description of the Active Risk Identification and Analysis System of the U.S. Food and Drug Administration Publications and Presentations
A Description of the Active Risk Identification and Analysis System of the U.S. Food and Drug Administration
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/us-food-and-drug-administration-s-sentinel-system-post The U.S. Food and Drug Administration’s Sentinel System: A Post-Market Active Drug Safety Surveillance System Publications and Presentations
The U.S. Food and Drug Administration’s Sentinel System: A Post-Market Active Drug Safety Surveillance System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/innovative-methods-evaluating-medical-product-safety-and Innovative Methods for Evaluating Medical Product Safety and Effectiveness Using Real World Data: The U.S. Food and Drug Administration’s Sentinel Innovation Center Publications and Presentations
Innovative Methods for Evaluating Medical Product Safety and Effectiveness Using Real World Data: The U.S. Food and Drug Administration’s Sentinel Innovation Center
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/covid-19 COVID-19 & Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE) Studies
COVID-19 & Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE)
Studies
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/winrevair-sotatercept Assessment of ARIA Sufficiency: Winrevair (sotatercept) Sufficiency Assessments
Assessment of ARIA Sufficiency: Winrevair (sotatercept)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/voquezna-vonoprozan Assessment of ARIA Sufficiency: Voquezna (vonoprozan) Sufficiency Assessments
Assessment of ARIA Sufficiency: Voquezna (vonoprozan)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/zepbound-tirzepatide Assessment of ARIA Sufficiency: Zepbound (tirzepatide) Sufficiency Assessments
Assessment of ARIA Sufficiency: Zepbound (tirzepatide)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/leqembi-lecanemab-irmb Assessment of ARIA Sufficiency: Leqembi (lecanemab-irmb) Sufficiency Assessments
Assessment of ARIA Sufficiency: Leqembi (lecanemab-irmb)
Sufficiency Assessments
https://www.sentinelinitiative.org/news-events/publications-presentations/triple-challenges-small-sample-size-both-exposure-and Triple Challenges – Small Sample Size in Both Exposure and Control Groups to Scan Rare Maternal Outcomes in a Signal Identification Approach: A Simulation Study Publications and Presentations
Triple Challenges – Small Sample Size in Both Exposure and Control Groups to Scan Rare Maternal Outcomes in a Signal Identification Approach: A Simulation Study
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/serious-infection-algorithm-defined-serious-infection Serious Infection Algorithm Defined in "Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools
Serious Infection Algorithm Defined in "Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-0 Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis Analyses
Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/xofluza-baloxavir Xofluza (Baloxavir) & Signal Identification Studies
Xofluza (Baloxavir) & Signal Identification
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/use-sentinel-system-examine-medical-product-use-and-outcomes Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy Publications and Presentations
Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format Methods, Data, & Tools
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/simple-cox-approach-estimating-risk-ratios-without-sharing A Simple Cox Approach to Estimating Risk Ratios Without Sharing Individual-Level Data in Multi-Site Studies Publications and Presentations
A Simple Cox Approach to Estimating Risk Ratios Without Sharing Individual-Level Data in Multi-Site Studies
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/distributed-regression-analysis-application-package-using A Distributed Regression Analysis Application Package Using SAS Publications and Presentations
A Distributed Regression Analysis Application Package Using SAS
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-dipeptidyl-peptidase-4-dpp-4 Counts and Characteristics of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor or Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Users with Type 2 Diabetes: A Descriptive Analysis Analyses
Counts and Characteristics of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor or Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Users with Type 2 Diabetes: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/future-data-rich-pharmacoepidemiology-studies-transitioning A Future of Data-Rich Pharmacoepidemiology Studies - Transitioning to Large-Scale Linked EHR+Claims Data Publications and Presentations
A Future of Data-Rich Pharmacoepidemiology Studies - Transitioning to Large-Scale Linked EHR+Claims Data
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies
Brexafemme (Ibrexafungerp) & Use in Pregnancy
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-patients-updated-0 Utilization of Ibrexafungerp in Pregnant Patients: An Updated Descriptive Analysis Analyses
Utilization of Ibrexafungerp in Pregnant Patients: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-methotrexate-descriptive-analysis-trinetx Utilization of Methotrexate: A Descriptive Analysis in TriNetX Analyses
Utilization of Methotrexate: A Descriptive Analysis in TriNetX
Analyses
https://www.sentinelinitiative.org/studies/drugs/glucagon-peptide-1-receptor-agonists Glucagon-Like Peptide-1 Receptor Agonists & Intentional Self-Harm Studies
Glucagon-Like Peptide-1 Receptor Agonists & Intentional Self-Harm
Studies
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intentional-self-harm-algorithm-defined-intentional-2 Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis" Methods, Data, & Tools
Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intentional-self-harm-algorithm-defined-intentional-1 Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools
Intentional Self-Harm Algorithm Defined in "Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-glucagon-peptide-1-receptor Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis Analyses
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-glucagon-peptide-1-0 Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis Analyses
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/drugs-risk-evaluation-and-mitigation-strategies-rems-employ-elements-assure-safe-use Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization Studies
Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/research-action-podcast-transforming-public-health Research in Action Podcast: Transforming Public Health with Unstructured Data and NLP in FDA's Sentinel Initiative Publications and Presentations
Research in Action Podcast: Transforming Public Health with Unstructured Data and NLP in FDA's Sentinel Initiative
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/identifying-pediatric-hypertension-observational-data Identifying Pediatric Hypertension in Observational Data: Comparing Clinical and Claims Cohorts in Real World Data Publications and Presentations
Identifying Pediatric Hypertension in Observational Data: Comparing Clinical and Claims Cohorts in Real World Data
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/prevalence-selected-conditions-among-individuals Prevalence of Selected Conditions Among Individuals with Childbearing Potential: A Descriptive Analysis Analyses
Prevalence of Selected Conditions Among Individuals with Childbearing Potential: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2017-third Duration of Follow Up for New Molecular Entities Approved in 2017: Third Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2017: Third Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2018-second Duration of Follow Up for New Molecular Entities Approved in 2018: Second Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2018: Second Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2019-second Duration of Follow Up for New Molecular Entities Approved in 2019: Second Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2019: Second Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2020-first Duration of Follow Up for New Molecular Entities Approved in 2020: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2020: First Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2021-first Duration of Follow Up for New Molecular Entities Approved in 2021: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2021: First Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/new-molecular-entities-nmes New Molecular Entities (NMEs) & Utilization Characterization Studies
New Molecular Entities (NMEs) & Utilization Characterization
Studies
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools
Sentinel Routine Querying System
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/dupixent-dupilumab Dupixent (Dupilumab) & Signal Identification Studies
Dupixent (Dupilumab) & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-dupilumab-descriptive-analysis Utilization of Dupilumab: A Descriptive Analysis Assessments
Utilization of Dupilumab: A Descriptive Analysis
Assessments
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/sentinel-views Sentinel Views Methods, Data, & Tools
Sentinel Views
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/confounding-conditions Confounding Conditions & Characterization Studies
Confounding Conditions & Characterization
Studies
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/covid-19-severity-algorithm-defined-risk-adverse COVID-19 Severity Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
COVID-19 Severity Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/low-birth-weight-algorithm-defined-risk-adverse Low Birth Weight Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Low Birth Weight Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/lumisight-pegulicianine Assessment of ARIA Sufficiency: Lumisight (pegulicianine) Sufficiency Assessments
Assessment of ARIA Sufficiency: Lumisight (pegulicianine)
Sufficiency Assessments
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-congenital-malformation-algorithm-defined-risk Major Congenital Malformation Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Major Congenital Malformation Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/microcephaly-algorithm-defined-risk-adverse-neonatal Microcephaly Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Microcephaly Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-neonatal-health-outcomes-among-pregnant Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis Analyses
Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/small-gestational-age-algorithm-defined-risk-adverse Small for Gestational Age Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Small for Gestational Age Algorithm Defined in "Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/overview-cder-s-real-world-evidence-demonstration-projects Overview of CDER’s Real-World Evidence Demonstration Projects Sentinel Initiative Events
Overview of CDER’s Real-World Evidence Demonstration Projects
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/pediatric-patients-0 Pediatric Patients & Characterization Studies
Pediatric Patients & Characterization
Studies
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/caesarean-section-algorithm-defined-risk-adverse Caesarean Section Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Caesarean Section Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/covid-19-severity-algorithm-defined-risk-adverse-0 COVID-19 Severity Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
COVID-19 Severity Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gestational-diabetes-mellitus-algorithm-defined-risk Gestational Diabetes Mellitus Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Gestational Diabetes Mellitus Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/maternal-death-algorithm-defined-risk-adverse-maternal Maternal Death Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Maternal Death Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/preeclampsia-algorithm-defined-risk-adverse-maternal Preeclampsia Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Preeclampsia Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/preterm-birth-algorithm-defined-risk-adverse-maternal Preterm Birth Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis" Methods, Data, & Tools
Preterm Birth Algorithm Defined in "Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-maternal-health-outcomes-among-pregnant Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis Analyses
Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-pregnant-patients-covid Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis Analyses
Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table-0 Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: An Updated Descriptive Analysis Analyses
Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/makena-hydroxyprogesterone-caproate-injection-and-its-generics Makena (Hydroxyprogesterone Caproate Injection) and Its Generics & Use in Pregnancy Studies
Makena (Hydroxyprogesterone Caproate Injection) and Its Generics & Use in Pregnancy
Studies
https://www.sentinelinitiative.org/studies/drugs/pediatric-patients Pediatric Patients & Hypertension Studies
Pediatric Patients & Hypertension
Studies
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/kisunla-donanemab-azbt Assessment of ARIA Sufficiency: Kisunla (donanemab-azbt) Sufficiency Assessments
Assessment of ARIA Sufficiency: Kisunla (donanemab-azbt)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/rinvoq-upadacitinib-0 Assessment of ARIA Sufficiency: Rinvoq (upadacitinib) Sufficiency Assessments
Assessment of ARIA Sufficiency: Rinvoq (upadacitinib)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-dabigatran-rivaroxaban Characteristics and Drug Utilization in Dabigatran, Rivaroxaban, and Apixaban Initiators Aged 64 or Younger: A Descriptive Analysis Analyses
Characteristics and Drug Utilization in Dabigatran, Rivaroxaban, and Apixaban Initiators Aged 64 or Younger: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-bleeding-algorithm-defined-1 Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools
Gastrointestinal Bleeding Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intracranial-hemorrhage-algorithm-defined-2 Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools
Intracranial Hemorrhage Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/major-extracranial-bleeding-algorithm-defined-2 Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools
Major Extracranial Bleeding Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/thromboembolic-stroke-algorithm-defined-2 Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis" Methods, Data, & Tools
Thromboembolic Stroke Algorithm Defined in "Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-intracranial-hemorrhage-0 Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis Analyses
Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis Analyses
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic-0 Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified Analysis Analyses
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/iqirvo-elafibranor Assessment of ARIA Sufficiency: Iqirvo (elafibranor) Sufficiency Assessments
Assessment of ARIA Sufficiency: Iqirvo (elafibranor)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/trends-healthcare-utilization-during-covid-19-pandemic Trends in Healthcare Utilization During the COVID-19 Pandemic Studies
Trends in Healthcare Utilization During the COVID-19 Pandemic
Studies
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-ispe-annual-meeting 2024 ISPE Annual Meeting Sentinel Initiative Events
2024 ISPE Annual Meeting
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/hydrochlorothiazide-1 Hydrochlorothiazide & Utilization Studies
Hydrochlorothiazide & Utilization
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydrochlorothiazide-use-following-labeling-update-include-1 Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Updated Interrupted Time Series Analysis Analyses
Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Updated Interrupted Time Series Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/interrupted-time-series Interrupted Time Series & Use Case Testing Studies
Interrupted Time Series & Use Case Testing
Studies
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/piasky-crovalimab-akkz-0 Assessment of ARIA Sufficiency: Piasky (crovalimab-akkz) Sufficiency Assessments
Assessment of ARIA Sufficiency: Piasky (crovalimab-akkz)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/jesduvroq-daprodustat Assessment of ARIA Sufficiency: Jesduvroq (daprodustat) Sufficiency Assessments
Assessment of ARIA Sufficiency: Jesduvroq (daprodustat)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-prurigo-nodularis-and Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis Analyses
Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/immunosuppressive-medications Immunosuppressive Medications & Duration of Follow-Up Analyses
Immunosuppressive Medications & Duration of Follow-Up
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/assessing-treatment-effects-observational-data-missing Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods Sentinel Initiative Events
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods
Sentinel Initiative Events
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/regional-health-information-exchanges-critical-national Regional Health Information Exchanges as Critical National Infrastructure: Supporting Federal Agency Missions Sentinel Initiative Events 09/25/2024
Regional Health Information Exchanges as Critical National Infrastructure: Supporting Federal Agency Missions
Sentinel Initiative Events
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2024-16th-annual-sentinel-initiative-public-workshop 2024 16th Annual Sentinel Initiative Public Workshop Sentinel Initiative Events 11/07/2024
2024 16th Annual Sentinel Initiative Public Workshop
Sentinel Initiative Events